SCHEMBL18954802

SCHEMBL18954802

O=C1C(=O)N(Cc2ccccc2Cl)c2ccc(S(=O)(=O)[O-])cc21.[Na+]

nearest known ligand 0.60

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CA12 known ✓ O43570 8/20 0.59
▸ CA1 known ✓ P00915 8/20 0.59
▸ CA2 known ✓ P00918 8/20 0.59
▸ CHRM5 P08912 1/20 0.60
▸ CA9 Q16790 8/20 0.59
▸ CASP3 P42574 2/20 0.53
▸ CASP7 P55210 2/20 0.53
▸ CASP6 P55212 2/20 0.53
▸ ALDH1A1 P00352 1/20 0.50
▸ ALDH2 P05091 1/20 0.50
▸ ALDH3A1 P30838 1/20 0.50
▸ ACHE P22303 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954800 0.86 CHRM5 (0.58) CHRM5CA12CA1CA2CA9
SCHEMBL18954843 0.86 CA12 (0.58) CHRM5CA12CA1CA2CA9
SCHEMBL18954720 0.85 CA1 (0.60) CHRM5CA12CA1CA2CA9
SCHEMBL18954743 0.85 CHRM5 (0.60) CHRM5CA12CA1CA2CA9
SCHEMBL18954824 0.85 CA1 (0.60) CHRM5CA12CA1CA2CA9
SCHEMBL18954575 0.85 CA1 (0.78) CHRM5CA12CA1CA2CA9
SCHEMBL18954922 0.84 CA1 (0.79) CHRM5CA12CA1CA2CA9
SCHEMBL9904848 0.83 ALDH3A1 (0.72) CHRM5CA12CA1CA2CA9
SCHEMBL18954683 0.82 CHRM5 (0.71) CHRM5CA12CA1CA2CA9
SCHEMBL18954747 0.82 CA12 (0.54) CHRM5CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback